Neonatal Dexamethasone Exposure on Hypoxia- Ischemia-Induced White Matter Injury
碩士 === 國立成功大學 === 藥理學研究所 === 102 === The synthetic glucocorticoid dexamethasone (DEX) has been widely used to prevent or lessen the morbidity of chronic lung disease (CLD) by facilitating surfactant synthesis in pulmonary alveolus in preterm infants. Typically, DEX were administered during a period...
Main Authors: | Chia-YuYeh, 葉佳妤 |
---|---|
Other Authors: | Kuei-Sen Hsu |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/66848249493074955700 |
Similar Items
-
Synaptic Injury in the Thalamus Accompanies White Matter Injury in Hypoxia/Ischemia-Mediated Brain Injury in Neonatal Rats
by: Na Liu, et al.
Published: (2019-01-01) -
Role of recurrent hypoxia-ischemia in preterm white matter injury severity.
by: Matthew W Hagen, et al.
Published: (2014-01-01) -
Protective role of autophagy in neonatal hypoxia–ischemia induced brain injury
by: Silvia Carloni, et al.
Published: (2008-12-01) -
Efferocytosis Mediated Modulation of Injury after Neonatal Brain Hypoxia-Ischemia
by: Jana Krystofova Mike, et al.
Published: (2021-04-01) -
Antimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damage
by: Eridan eRocha-Ferreira, et al.
Published: (2015-02-01)